Hypoparathyroidism clinical trials at UCSF

3 in progress, 0 open to eligible people

Showing trials for

  • Encaleret Compared to Standard of Care in Participants With ADH1

    Sorry, in progress, not accepting new patients

    The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).

    Oakland 5378538, California 5332921 and other locations

  • Parathyroid Allotransplant for Treatment of Hypoparathyroidism

    Sorry, not yet accepting patients

    This study is being done to see if transplanting parathyroid tissue into the forearm will help hypo-parathyroid patients achieve parathyroid hormone (PTH) levels that would help normalize their serum calcium and phosphorus levels. The parathyroid tissue used in this study will come from cadaveric tissues that were donated at the time of the death of the donor(s).

    San Francisco 5391959, California 5332921

  • ADH1 and ADH2 Disease Monitoring Study (DMS)

    Sorry, in progress, not accepting new patients

    A global, multi-center, Disease Monitoring Study (DMS) in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1) or Autosomal Dominant Hypocalcemia Type 2 (ADH2) designed to characterize ADH1 and ADH2 disease presentation and progression through retrospective (past) and longitudinal prospective (over time into the future) data collection.

    Oakland 5378538, California 5332921 and other locations

Our lead scientists for Hypoparathyroidism research studies include .

Last updated: